LTKBF yields 0.78% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, LTKBF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LTKBF + PFE for your $10,000?
Logistec Corporation, together with its subsidiaries, provides cargo handling and other services to marine, industrial, and municipal customers in Canada and the United States. It operates in two segments, Marine Services and Environmental Services. The company provides specialized cargo handling services, which include container, bulk, breakbulk, and project cargo, as well as other services through the operation of 80 terminals in 54 ports in North America. It also stevedoring, cargo loading and unloading, container stuffing and destuffing, ship dockage, road transportation, and storage services, as well as tailgating, including truck loading and discharging services; and marine agency services to foreign shipowners and operators serving the Canadian market. In addition, the company is involved in the renewal of underground water mains, dredging, dewatering, contaminated soils and materials management, site remediation, and risk assessment, as well as manufacturing of fluid transportation products. Further, it offers turnkey solutions for the environmental assessment of properties and the remediation of impacted soils, groundwater, and lagoons; and services for proper handling of hazardous materials in buildings and the replacement of underground hydrocarbon storage infrastructure, including the characterization and remediation of sites and risk assessment, as well as contaminated soils and materials management. The company was formerly known as Quebec Terminals Ltd. and changed its name to Logistec Corporation in April 1969. Logistec Corporation was incorporated in 1952 and is headquartered in Montreal, Canada.
Full LTKBF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.